BackPolyrizon Overview

Polyrizon Current Assets

Polyrizon's current assets is $16M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$16.29M
↑ 1.63% YoYΔ $262000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Polyrizon Current Assets History

Loading

Polyrizon vs. peers: Current Assets Comparison

Loading

Polyrizon Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Polyrizon (PLRZ) FAQ

As of the most recent data (June 2026), PLRZ shows a current assets of $16M. That compares with $16M in the prior-year period — up 1.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PLRZ's current assets is now $16M (was $16M) — a 1.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Polyrizon is outperforming or lagging.

Tracking PLRZ's current assets over time shows whether Polyrizon is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $16M in the prior-year period — up 1.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Polyrizon's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $16M) with ownership activity and broader fundamentals.

Polyrizon's current assets is $16M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.